vs
Acadia Healthcare Company, Inc.（ACHC）与Sunrun Inc.（RUN）财务数据对比。点击上方公司名可切换其他公司
Sunrun Inc.的季度营收约是Acadia Healthcare Company, Inc.的1.4倍（$1.2B vs $829.0M），Sunrun Inc.净利率更高（8.9% vs 0.5%，领先8.4%），Sunrun Inc.同比增速更快（123.5% vs 7.5%），过去两年Sunrun Inc.的营收复合增速更高（59.0% vs 2.0%）
阿卡迪亚医疗公司是美国的营利性行为医疗健康服务提供商，目前在美国及波多黎各地区运营着超过225家医疗机构，搭建了覆盖广泛的行为健康服务网络，为有相关需求的人群提供专业的心理健康与行为干预服务。
Sunrun Inc.是美国知名的光伏系统及电池储能产品供应商，业务以服务住宅客户为主，2007年成立，总部位于加利福尼亚州旧金山，致力于为家庭用户提供高效的清洁能源解决方案。
ACHC vs RUN — 直观对比
营收规模更大
RUN
是对方的1.4倍
$829.0M
营收增速更快
RUN
高出116.0%
7.5%
净利率更高
RUN
高出8.4%
0.5%
两年增速更快
RUN
近两年复合增速
2.0%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $829.0M | $1.2B |
| 净利润 | $4.5M | $103.6M |
| 毛利率 | — | — |
| 营业利润率 | — | 8.4% |
| 净利率 | 0.5% | 8.9% |
| 营收同比 | 7.5% | 123.5% |
| 净利润同比 | -50.8% | 103.7% |
| 每股收益（稀释后） | $0.05 | $0.38 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACHCRUN
| Q1 26 | $829.0M | — | ||
| Q4 25 | $821.5M | $1.2B | ||
| Q3 25 | $851.6M | $724.6M | ||
| Q2 25 | $869.2M | $569.3M | ||
| Q1 25 | $770.5M | $504.3M | ||
| Q4 24 | $774.2M | $518.5M | ||
| Q3 24 | $815.6M | $537.2M | ||
| Q2 24 | $796.0M | $523.9M |
净利润ACHCRUN
| Q1 26 | $4.5M | — | ||
| Q4 25 | $-1.2B | $103.6M | ||
| Q3 25 | $36.2M | $16.6M | ||
| Q2 25 | $30.1M | $279.8M | ||
| Q1 25 | $8.4M | $50.0M | ||
| Q4 24 | $32.6M | $-2.8B | ||
| Q3 24 | $68.1M | $-83.8M | ||
| Q2 24 | $78.5M | $139.1M |
营业利润率ACHCRUN
| Q1 26 | — | — | ||
| Q4 25 | -142.4% | 8.4% | ||
| Q3 25 | 4.7% | 0.5% | ||
| Q2 25 | 5.8% | -19.7% | ||
| Q1 25 | 1.7% | -22.8% | ||
| Q4 24 | 4.9% | -628.0% | ||
| Q3 24 | 12.1% | -23.8% | ||
| Q2 24 | 13.4% | -24.4% |
净利率ACHCRUN
| Q1 26 | 0.5% | — | ||
| Q4 25 | -143.3% | 8.9% | ||
| Q3 25 | 4.3% | 2.3% | ||
| Q2 25 | 3.5% | 49.1% | ||
| Q1 25 | 1.1% | 9.9% | ||
| Q4 24 | 4.2% | -542.7% | ||
| Q3 24 | 8.4% | -15.6% | ||
| Q2 24 | 9.9% | 26.5% |
每股收益（稀释后）ACHCRUN
| Q1 26 | $0.05 | — | ||
| Q4 25 | $-12.98 | $0.38 | ||
| Q3 25 | $0.40 | $0.06 | ||
| Q2 25 | $0.33 | $1.07 | ||
| Q1 25 | $0.09 | $0.20 | ||
| Q4 24 | $0.36 | $-12.59 | ||
| Q3 24 | $0.74 | $-0.37 | ||
| Q2 24 | $0.85 | $0.55 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $158.5M | — |
| 总债务越低越好 | $2.5B | $14.7B |
| 股东权益账面价值 | $2.0B | $3.1B |
| 总资产 | $5.5B | $22.6B |
| 负债/权益比越低杠杆越低 | 1.29× | 4.69× |
8季度趋势，按日历期对齐
现金及短期投资ACHCRUN
| Q1 26 | $158.5M | — | ||
| Q4 25 | $133.2M | — | ||
| Q3 25 | $118.7M | — | ||
| Q2 25 | $131.4M | — | ||
| Q1 25 | $91.2M | — | ||
| Q4 24 | $76.3M | — | ||
| Q3 24 | $82.1M | — | ||
| Q2 24 | $77.2M | — |
总债务ACHCRUN
| Q1 26 | $2.5B | — | ||
| Q4 25 | $2.5B | $14.7B | ||
| Q3 25 | $2.3B | $14.6B | ||
| Q2 25 | $2.3B | $14.0B | ||
| Q1 25 | $2.2B | $13.6B | ||
| Q4 24 | $2.0B | $12.9B | ||
| Q3 24 | $1.9B | $12.5B | ||
| Q2 24 | $1.8B | $12.0B |
股东权益ACHCRUN
| Q1 26 | $2.0B | — | ||
| Q4 25 | $1.9B | $3.1B | ||
| Q3 25 | $3.1B | $3.0B | ||
| Q2 25 | $3.1B | $2.9B | ||
| Q1 25 | $3.0B | $2.6B | ||
| Q4 24 | $3.1B | $2.6B | ||
| Q3 24 | $3.0B | $5.3B | ||
| Q2 24 | $3.0B | $5.4B |
总资产ACHCRUN
| Q1 26 | $5.5B | — | ||
| Q4 25 | $5.5B | $22.6B | ||
| Q3 25 | $6.4B | $22.2B | ||
| Q2 25 | $6.3B | $21.2B | ||
| Q1 25 | $6.1B | $20.4B | ||
| Q4 24 | $6.0B | $19.9B | ||
| Q3 24 | $5.9B | $22.1B | ||
| Q2 24 | $5.7B | $21.4B |
负债/权益比ACHCRUN
| Q1 26 | 1.29× | — | ||
| Q4 25 | 1.28× | 4.69× | ||
| Q3 25 | 0.74× | 4.90× | ||
| Q2 25 | 0.74× | 4.80× | ||
| Q1 25 | 0.72× | 5.19× | ||
| Q4 24 | 0.64× | 5.05× | ||
| Q3 24 | 0.62× | 2.36× | ||
| Q2 24 | 0.62× | 2.23× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $61.5M | $96.9M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 13.78× | 0.94× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ACHCRUN
| Q1 26 | $61.5M | — | ||
| Q4 25 | $-86.3M | $96.9M | ||
| Q3 25 | $73.2M | $-121.5M | ||
| Q2 25 | $133.5M | $-292.7M | ||
| Q1 25 | $11.5M | $-104.2M | ||
| Q4 24 | $116.7M | $-258.4M | ||
| Q3 24 | $163.1M | $-156.2M | ||
| Q2 24 | $171.1M | $-208.5M |
自由现金流ACHCRUN
| Q1 26 | — | — | ||
| Q4 25 | $-179.5M | — | ||
| Q3 25 | $-63.0M | — | ||
| Q2 25 | $-34.2M | — | ||
| Q1 25 | $-163.2M | — | ||
| Q4 24 | $-86.8M | — | ||
| Q3 24 | $-27.1M | $-156.4M | ||
| Q2 24 | $16.9M | — |
自由现金流率ACHCRUN
| Q1 26 | — | — | ||
| Q4 25 | -21.8% | — | ||
| Q3 25 | -7.4% | — | ||
| Q2 25 | -3.9% | — | ||
| Q1 25 | -21.2% | — | ||
| Q4 24 | -11.2% | — | ||
| Q3 24 | -3.3% | -29.1% | ||
| Q2 24 | 2.1% | — |
资本支出强度ACHCRUN
| Q1 26 | — | — | ||
| Q4 25 | 11.3% | — | ||
| Q3 25 | 16.0% | — | ||
| Q2 25 | 19.3% | — | ||
| Q1 25 | 22.7% | — | ||
| Q4 24 | 26.3% | — | ||
| Q3 24 | 23.3% | 0.0% | ||
| Q2 24 | 19.4% | — |
现金转化率ACHCRUN
| Q1 26 | 13.78× | — | ||
| Q4 25 | — | 0.94× | ||
| Q3 25 | 2.02× | -7.33× | ||
| Q2 25 | 4.43× | -1.05× | ||
| Q1 25 | 1.37× | -2.08× | ||
| Q4 24 | 3.58× | — | ||
| Q3 24 | 2.39× | — | ||
| Q2 24 | 2.18× | -1.50× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACHC
| Acute Inpatient Psychiatric Facilities | $471.0M | 57% |
| Other | $140.0M | 17% |
| Specialty Treatment Facilities | $128.0M | 15% |
| Residential Treatment Facilities | $90.0M | 11% |
RUN
| Products | $692.3M | 60% |
| Customer Agreements | $435.2M | 38% |
| Manufactured Product Other | $56.7M | 5% |
| Incentives | $31.3M | 3% |
